Phase II/III start mid June recruiting , duration 48 weeks , FDA may well be satisfied at the 6 month mark , EU require the full 48 weeks.
Next Catalyst Orphan Drug Designation 40 to 90 days , $1.8m grant from Fight MND ..
If Management had pushed the News Pre Open the level of dilution would have been diminished considerably as we do require at Least $10m USD for the Phase II/III prior to kick off... Having Funds in Place is to protect the Trial Patients and integrity of the Trial.
The Science is sound,,,, many know my thoughts surrounding Messaging ... Yesterday was a Pivotal Moment in History and PAA Management and the PR firm fumbled the ball .....
Near Term Catalysts,, check my Posts NZT
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-575
-
- There are more pages in this discussion • 850 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |